$22 billion in exit value has shifted the center of gravity for artificial intelligence capital, as a wave of Chinese listings in Hong Kong starkly outpaces the cooling reception for technology IPOs in the United States. While Wall Street contends with a growing skepticism toward software incumbents, Hong Kong’s public markets are experiencing a concentrated surge driven by four major AI-focused debuts: Z.ai, MiniMax, Biren Technology, and Iluvatar CoreX Semiconductor.
The Hong Kong AI Premium
The success of these firms, alongside the surgical robotics company Edge Medical, has funneled more than $24 billion into the Hong Kong exchange during the first quarter. According to Harrison Rolfes, a senior research analyst at PitchBook, this performance is not merely a result of market liquidity, but a fundamental shift in perception. Rolfes notes that the "DeepSeek moment" in early 2025 acted as a catalyst, forcing a rerating of Chinese AI capabilities among global investors.
This momentum is bolstered by what Rolfes describes as a “national champion premium.” Unlike many U.S. tech listings that have entered the market at aggressive valuations, these Chinese firms arrived with more digestible entry multiples. This strategic pricing, combined with a focus on tangible revenue and defensible vertical positioning in semiconductor design and robotics, has created a stark divergence from the performance of American counterparts.
A Record Stretch of Underperformance
The contrast is most visible when tracking the post-IPO trajectory of U.S. technology companies. PitchBook data reveals that the median U.S. IPO has underperformed its benchmark by 42 percentage points within 120 days of listing over the trailing 12 months. This figure represents the worst stretch in the firm's dataset, surpassing the previous record of a 32-percentage-point lag seen during the 2021 post-boom correction.
The data indicates that the optimism accompanying these U.S. debuts is fading rapidly. Currently, roughly 66% of companies that have gone public since the start of 2025 are trading below their initial offering prices. As lockup expirations approach and market scrutiny intensifies, this progressive deterioration suggests that investors are moving from initial excitement to a more rigorous fundamental reassessment.
The SaaSpocalypse Risk
The disparity in performance is largely tied to how the market interprets the impact of artificial intelligence on legacy business models. While infrastructure-heavy firms like CoreWeave have seen their shares nearly triple, broader SaaS (Software as a Service) markets are struggling. High-profile U.S. laggards include eToro, down 45.2%; Netskope, down 61%; Klarna, down 67.1%; Figma, down 85.7%; and Gemini Space Station, down 86.3%.
Investors are increasingly pricing in a "SaaSpocalypse," a phenomenon where AI is viewed as a displacement risk for incumbent software firms rather than a catalyst for growth. This skepticism has effectively decoupled the valuation of private AI unicorns from the public software stocks that were previously seen as their closest peers.
Implications for Your Portfolio
For investors, the immediate takeaway is the need for a geographic recalibration. The persistent valuation premiums in Hong Kong suggest that the "national champion" narrative carries more weight in current market cycles than the speculative growth stories dominating the U.S. tech sector.
As you assess your exposure to the global AI boom, the next reading of the median IPO performance relative to the Morningstar U.S. Market Broad Growth Extended Index will serve as the primary signal. If the gap between benchmark growth and recent U.S. listings continues to widen, it will confirm that the market is prioritizing the proven, revenue-backed positioning of Asian AI firms over the displaced software giants of the West.
